Westchester Capital Management (New York)’s Phoenix Biotech Acquisition Corp. Unit PBAXU Stock Holding History
Bought
Maintained
Sold
Other funds holding PBAXU
Westchester Capital Management (New York)'s PBAXU Position: Q4 2022 in Review
Westchester Capital Management (New York) sold out of Phoenix Biotech Acquisition Corp. Unit (PBAXU) in Q4 2022, closing a stake of 150,000 shares — an estimated $1.52M sold.
Westchester Capital Management (New York) first reported a position in PBAXU in Q4 2021 and held it in 4 quarters. The position peaked at $1.52M in Q3 2022. 3 funds tracked by Wall St. Rank hold PBAXU as of Q4 2022.
- Westchester Capital Management (New York) reported no remaining Phoenix Biotech Acquisition Corp. Unit position as of Q4 2022 after selling out during the quarter.
- Westchester Capital Management (New York) sold 150,000 Phoenix Biotech Acquisition Corp. Unit shares in Q4 2022, an estimated $1.52M.
- Westchester Capital Management (New York) first reported a position in Phoenix Biotech Acquisition Corp. Unit in Q4 2021 and held it in 4 quarters.
- Westchester Capital Management (New York)'s Phoenix Biotech Acquisition Corp. Unit position peaked at $1.52M in Q3 2022.
- 3 funds tracked by Wall St. Rank held Phoenix Biotech Acquisition Corp. Unit as of Q4 2022.
Based on Westchester Capital Management (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.